Conference
Randomized phase II-III study of matrix metalloproteinase inhibitor (MMPI) BMS-275291 in combination with paclitaxel (P) and carboplatin (C) in advanced non-small cell lung cancer (NSCLC): NCIC-CTG BR. 18.
Authors
Leighl NB; Shepherd F; Paz-Ares L; Douillard JY; Peschel C; Arnold A; Tu D; Galbraith S; Hann K; Seymour L
Volume
22
Pagination
pp. 626S-626S
Publisher
AMER SOC CLINICAL ONCOLOGY
Publication Date
July 15, 2004
Name of conference
40th Annual Meeting of the American-Society-of-Clinical-Oncology
Conference place
LA, New Orleans
Conference start date
June 5, 2004
Conference end date
June 8, 2004
Conference proceedings
JOURNAL OF CLINICAL ONCOLOGY
Issue
14
ISSN
0732-183X